Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice
- PMID: 22126863
- PMCID: PMC3308587
- DOI: 10.3791/3188
Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice
Abstract
Type 2 diabetes is characterized by a defect in insulin action. The hyperinsulinemic-euglycemic clamp, or insulin clamp, is widely considered the "gold standard" method for assessing insulin action in vivo. During an insulin clamp, hyperinsulinemia is achieved by a constant insulin infusion. Euglycemia is maintained via a concomitant glucose infusion at a variable rate. This variable glucose infusion rate (GIR) is determined by measuring blood glucose at brief intervals throughout the experiment and adjusting the GIR accordingly. The GIR is indicative of whole-body insulin action, as mice with enhanced insulin action require a greater GIR. The insulin clamp can incorporate administration of isotopic 2[(14)C]deoxyglucose to assess tissue-specific glucose uptake and [3-(3)H]glucose to assess the ability of insulin to suppress the rate of endogenous glucose appearance (endoRa), a marker of hepatic glucose production, and to stimulate the rate of whole-body glucose disappearance (Rd). The miniaturization of the insulin clamp for use in genetic mouse models of metabolic disease has led to significant advances in diabetes research. Methods for performing insulin clamps vary between laboratories. It is important to note that the manner in which an insulin clamp is performed can significantly affect the results obtained. We have published a comprehensive assessment of different approaches to performing insulin clamps in conscious mice(1) as well as an evaluation of the metabolic response of four commonly used inbred mouse strains using various clamp techniques(2). Here we present a protocol for performing insulin clamps on conscious, unrestrained mice developed by the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC; URL: www.mc.vanderbilt.edu/mmpc). This includes a description of the method for implanting catheters used during the insulin clamp. The protocol employed by the Vanderbilt MMPC utilizes a unique two-catheter system(3). One catheter is inserted into the jugular vein for infusions. A second catheter is inserted into the carotid artery, which allows for blood sampling without the need to restrain or handle the mouse. This technique provides a significant advantage to the most common method for obtaining blood samples during insulin clamps which is to sample from the severed tip of the tail. Unlike this latter method, sampling from an arterial catheter is not stressful to the mouse(1). We also describe methods for using isotopic tracer infusions to assess tissue-specific insulin action. We also provide guidelines for the appropriate presentation of results obtained from insulin clamps.
Figures
Similar articles
-
Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse.Diabetes. 2006 Feb;55(2):390-7. doi: 10.2337/diabetes.55.02.06.db05-0686. Diabetes. 2006. PMID: 16443772
-
Hyperinsulinemic-euglycemic clamp in the conscious rat.J Vis Exp. 2011 Feb 7;(48):2432. doi: 10.3791/2432. J Vis Exp. 2011. PMID: 21339723 Free PMC article.
-
Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo.Methods Mol Biol. 2009;560:221-38. doi: 10.1007/978-1-59745-448-3_15. Methods Mol Biol. 2009. PMID: 19504253
-
The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model.Horm Metab Res Suppl. 1990;24:49-56. Horm Metab Res Suppl. 1990. PMID: 2272626 Review.
-
Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis.Eur J Endocrinol. 2015 Jul;173(1):101-9. doi: 10.1530/EJE-14-0911. Epub 2015 Apr 21. Eur J Endocrinol. 2015. PMID: 25899581 Review.
Cited by
-
The mouse metabolic phenotyping center (MMPC) live consortium: an NIH resource for in vivo characterization of mouse models of diabetes and obesity.Mamm Genome. 2024 Dec;35(4):485-496. doi: 10.1007/s00335-024-10067-y. Epub 2024 Aug 27. Mamm Genome. 2024. PMID: 39191872 Free PMC article. Review.
-
Hepatic Gi signaling regulates whole-body glucose homeostasis.J Clin Invest. 2018 Feb 1;128(2):746-759. doi: 10.1172/JCI94505. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337301 Free PMC article.
-
VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications.Cell Metab. 2016 Apr 12;23(4):712-24. doi: 10.1016/j.cmet.2016.03.004. Cell Metab. 2016. PMID: 27076080 Free PMC article.
-
Rapid changes in the microvascular circulation of skeletal muscle impair insulin delivery during sepsis.Am J Physiol Endocrinol Metab. 2019 Jun 1;316(6):E1012-E1023. doi: 10.1152/ajpendo.00501.2018. Epub 2019 Mar 12. Am J Physiol Endocrinol Metab. 2019. PMID: 30860883 Free PMC article.
-
EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance.Nat Commun. 2022 Aug 10;13(1):4684. doi: 10.1038/s41467-022-32348-3. Nat Commun. 2022. PMID: 35948530 Free PMC article.
References
-
- Ayala JE, Bracy DP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 2006;55:390–397. - PubMed
-
- Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J. Biol. Chem. 1997;272:22570–22575. - PubMed
-
- Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, Kim JK. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes. 2004;53:1060–1067. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous